CDMO Capabilities PharmaTech LLC operates as a US-based CDMO offering end-to-end development and manufacturing for both Rx and OTC products, highlighting potential for partnerships in product scale-up, formulation development, and contract manufacturing services.

Quality & Compliance With a stated focus on FDA standards and Current Good Manufacturing Practices, there is an opportunity to engage manufacturers seeking reliable quality assurance, regulatory support, and compliant supply for US-market products.

US Facility Focus All products are manufactured at a USA facility, which can appeal to brands prioritizing domestic supply chains, import/export compliance, and reduced logistics risk for US-based distributors and marketing companies.

Mid market Scale Company size (approximately 51-200 employees) and revenue in the $10–25M range suggests agility for smaller to mid-sized partners seeking flexible collaboration, faster project cycles, and personalized program management.

Industry Positioning Operating alongside large pharma players, PharmaTech can offer specialized CDMO services to mid- to late-stage products, niche OTC lines, or accelerated timelines, presenting opportunities to win programs from smaller firms or divisions of bigger companies.